Cited by 71Protein Hydrolysis and Bioactive PeptidesBlood Pressure and Hypertension StudiesSodium Intake and Health

Retracted: Effects of Whey Peptides on Cardiovascular Disease Risk Factors

Open access
Pins, Joel J., Keenan, Joseph M.·2006·The Journal of Clinical Hypertension

Abstract

Previous studies have shown that peptides derived from milk proteins can improve blood pressure. Therefore, the authors tested the blood pressure-lowering effects of a hydrolyzed whey protein supplement rich in bioactive peptides. In a 6-week controlled study, 30 prehypertensive or stage 1 hypertensive subjects (blood pressure >or=120/80 mm Hg and <or=155/95 mm Hg) were randomized to receive 20 g/d of either a hydrolyzed whey protein (active treatment) or an unmodified whey protein (control treatment). Blood pressure, blood lipids, safety measures, side effects, and diet were evaluated throughout the trial. After completion of treatment, a 4-week follow-up was conducted. There was a mean reduction of 8.0+/-3.2 mm Hg in systolic blood pressure (P<.05) and of 5.5+/-2.1 mm Hg in diastolic blood pressure (P<.05) in the treatment group compared with the control group. Low-density lipoprotein cholesterol and high-sensitivity C-reactive protein were significantly improved by treatment. Whey-derived peptides might be a viable treatment option for prehypertensive and/or stage 1 hypertensive populations.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1524-6175.2006.05667.xThis paper is marked retracted.

Cites

23 of 23 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 2

  1. Nimmagudda R. New bioactive peptides for the nutritional industry. Oral presentation at: International SupplySide West Trade Show and Conference; April 18, 2002; Las Vegas, NV.
  2. The Journal of Clinical Hypertension® (ISSN 1524-6175) is published monthly by Le Jacq, Three Parklands Drive, Darien, CT 06820-3652. Copyright ©2006 by Le Jacq, All rights reserved. No part of this publication may be reproduced or transmitted in any form or by any means, electronic or mechanical, including photocopy, recording, or any information storage and retrieval system, without permission in writing from the publishers. The opinions and ideas expressed in this publication are those of the authors and do not necessarily reflect those of the Editors or Publisher. For copies in excess of 25 or for , please contact Sarah Howell at showell@lejacq.com or 203.656.

Cited by

Sorted by citations

Authors
Pins, J. J., & Keenan, J. M.
Affiliations
University of Minnesota (US)
Corresponding author
Pins, Joel J.
Venue
The Journal of Clinical Hypertension
Publisher
Wiley
Published
2006-11
Volume
8
Issue
11
Pages
775-782
ISSN
  • 1524-6175 (ISSN-L)
  • 1751-7176
OpenAlex
W1986733864
Cited by
71
References
23
Citations by year
2026: 1 · 2025: 1 · 2022: 1 · 2020: 1 · 2019: 7 · 2018: 3 · 2017: 2 · 2016: 3 · 2015: 5 · 2014: 7 · 2013: 8 · 2012: 9
FWCI
1.49
Type
journal article
Language
en
Status
Retracted
Open access
Locations
  • Journal of Clinical Hypertension (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • University of Minnesota
  • Olympus
  • National Institutes of Health
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Hydrolysis and Bioactive Peptides
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
  • Health Sciences › Nursing › Nutrition and Dietetics › Sodium Intake and Health
Keywords
whey peptides, whey protein hydrolysate, bioactive peptides, blood pressure reduction, hypertension, prehypertension, cardiovascular risk factors, LDL cholesterol, C-reactive protein, serum lipids
MeSH terms
Whey Proteins, Blood Pressure, Cardiovascular Diseases, Double-Blind Method, Female, Follow-Up Studies, Humans, Cholesterol, HDL, Cholesterol, LDL, Male, Middle Aged, Milk Proteins, Pilot Projects, Surveys and Questionnaires, Triglycerides, Treatment Outcome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review